US Stock MarketDetailed Quotes
BCAX Bicara Therapeutics
- 23.600
- -0.170-0.72%
Close Nov 7 16:00 ET
- 23.600
- 0.0000.00%
Post 16:00 ET
1.28BMarket Cap-17824P/E (TTM)
25.090High23.270Low193.35KVolume23.770Open23.770Pre Close4.61MTurnover1.11%Turnover RatioLossP/E (Static)54.39MShares28.09052wk High-7.34P/B413.00MFloat Cap18.33052wk Low--Dividend TTM17.50MShs Float28.090Historical High--Div YieldTTM7.66%Amplitude18.330Historical Low23.859Avg Price1Lot Size
Bicara Therapeutics News
Rodman & Renshaw Initiates Bicara Therapeutics(BCAX.US) With Buy Rating, Announces Target Price $48
Bicara Therapeutics Initiated at Overweight by Morgan Stanley
Bicara Therapeutics Analyst Ratings
TD Cowen Initiates Bicara Therapeutics(BCAX.US) With Buy Rating
Stifel Initiates Bicara Therapeutics(BCAX.US) With Buy Rating, Announces Target Price $47
Morgan Stanley Initiates Bicara Therapeutics(BCAX.US) With Buy Rating, Announces Target Price $35
Bicara Therapeutics: A Buy Rating on Promising Clinical Progress and Financial Fortitude
No More
Analysis
Price Target
No Data
Heat List
US
Overall
Symbol
Latest Price
% Chg
No Data
